Vincera Pharma, Inc Announces Exclusive License Agreement for Oncology Portfolio Including a Clinical-stage PTEFb/CDK9 Inhibitor and a Preclinical Bioconjugation Platform

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

Matt Turner
Patient Affordability

Joey Cohen
Medication Adherence

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach